Osteopore Ltd
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates spe… Read more
Osteopore Ltd (OSX) - Net Assets
Latest net assets as of June 2025: AU$-423.65K AUD
Based on the latest financial reports, Osteopore Ltd (OSX) has net assets worth AU$-423.65K AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.19 Million) and total liabilities (AU$4.62 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-423.65K |
| % of Total Assets | -10.11% |
| Annual Growth Rate | N/A |
| 5-Year Change | -96.6% |
| 10-Year Change | N/A |
| Growth Volatility | 95.26 |
Osteopore Ltd - Net Assets Trend (2016–2024)
This chart illustrates how Osteopore Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Osteopore Ltd (2016–2024)
The table below shows the annual net assets of Osteopore Ltd from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | AU$306.22K | -29.21% |
| 2023-12-31 | AU$432.60K | -79.47% |
| 2022-12-31 | AU$2.11 Million | -60.79% |
| 2021-12-31 | AU$5.37 Million | -40.28% |
| 2020-12-31 | AU$9.00 Million | +203.18% |
| 2019-12-31 | AU$2.97 Million | -29.90% |
| 2018-12-31 | AU$4.23 Million | +330.64% |
| 2017-12-31 | AU$-1.84 Million | -35.31% |
| 2016-12-31 | AU$-1.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Osteopore Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1560107900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$32.60 Million | 10645.98% |
| Other Comprehensive Income | AU$-14.23 Million | -4646.28% |
| Total Equity | AU$306.22K | 100.00% |
Osteopore Ltd Competitors by Market Cap
The table below lists competitors of Osteopore Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Signet International Holdings Inc
PINK:AQPW
|
$740.86K |
|
Core Assets Corp
OTCQB:CCOOF
|
$741.32K |
|
APPLIED OPTOELECTR
F:A59
|
$741.90K |
|
Reedy Lagoon Corporation Ltd
AU:RLC
|
$742.19K |
|
Baiya International Group Inc. Ordinary Shares
NASDAQ:BIYA
|
$740.45K |
|
Yubo International Biotech Limited
PINK:YBGJ
|
$740.35K |
|
2U, Inc.
PINK:TWOUQ
|
$739.61K |
|
Kedaung Indah Can Tbk
JK:KICI
|
$739.07K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Osteopore Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 432,603 to 306,220, a change of -126,383 (-29.2%).
- Net loss of 3,352,436 reduced equity.
- Share repurchases of 109,568 reduced equity.
- New share issuances of 3,115,824 increased equity.
- Other comprehensive income increased equity by 155,933.
- Other factors increased equity by 63,864.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-3.35 Million | -1094.78% |
| Share Repurchases | AU$109.57K | -35.78% |
| Share Issuances | AU$3.12 Million | +1017.51% |
| Other Comprehensive Income | AU$155.93K | +50.92% |
| Other Changes | AU$63.86K | +20.86% |
| Total Change | AU$- | -29.21% |
Book Value vs Market Value Analysis
This analysis compares Osteopore Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.79x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | AU$-0.04 | AU$0.01 | x |
| 2017-12-31 | AU$-0.05 | AU$0.01 | x |
| 2018-12-31 | AU$0.11 | AU$0.01 | x |
| 2019-12-31 | AU$1.54 | AU$0.01 | x |
| 2020-12-31 | AU$1.26 | AU$0.01 | x |
| 2021-12-31 | AU$0.69 | AU$0.01 | x |
| 2022-12-31 | AU$0.26 | AU$0.01 | x |
| 2023-12-31 | AU$0.01 | AU$0.01 | x |
| 2024-12-31 | AU$0.00 | AU$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Osteopore Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1094.78%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -119.24%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 10.24x
- Recent ROE (-1094.78%) is below the historical average (-290.10%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -475.06% | 0.24x | 0.00x | AU$-837.13K |
| 2017 | 0.00% | -73.20% | 1.75x | 0.00x | AU$-263.45K |
| 2018 | -20.56% | -93.09% | 0.17x | 1.28x | AU$-1.29 Million |
| 2019 | -80.29% | -575.36% | 0.10x | 1.44x | AU$-2.68 Million |
| 2020 | -21.63% | -129.33% | 0.15x | 1.14x | AU$-2.85 Million |
| 2021 | -67.39% | -325.33% | 0.19x | 1.12x | AU$-4.16 Million |
| 2022 | -200.09% | -249.09% | 0.47x | 1.72x | AU$-4.43 Million |
| 2023 | -1126.20% | -219.72% | 0.66x | 7.73x | AU$-4.92 Million |
| 2024 | -1094.78% | -119.24% | 0.90x | 10.24x | AU$-3.38 Million |
Industry Comparison
This section compares Osteopore Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $55,832,750
- Average return on equity (ROE) among peers: 6.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Osteopore Ltd (OSX) | AU$-423.65K | 0.00% | N/A | $740.73K |
| Austco Healthcare Ltd (AHC) | $19.30 Million | 17.74% | 0.41x | $56.41 Million |
| Nanosonics Ltd (NAN) | $182.20 Million | 7.12% | 0.30x | $545.85 Million |
| SDI Ltd (SDI) | $10.44 Million | -4.32% | 0.36x | $34.55 Million |
| Trajan Group Holdings Ltd (TRJ) | $11.39 Million | 6.06% | 1.69x | $17.96 Million |